Informed decision making about prostate cancer screening

dc.contributor.authorO'Callaghan, M.
dc.contributor.authorKichenadasse, G.
dc.contributor.authorVatandoust, S.
dc.contributor.authorMoretti, K.
dc.date.issued2015
dc.descriptionLetter to the Editor
dc.description.statementofresponsibilityMichael E. O, Callaghan, Ganessan Kichenadasse, Sina Vatandoust, Kim Moretti
dc.identifier.citationAnnals of Internal Medicine, 2015; 162(6):457-457
dc.identifier.doi10.7326/L15-5063
dc.identifier.issn1539-3704
dc.identifier.issn1539-3704
dc.identifier.orcidO'Callaghan, M. [0000-0001-5038-5859] [0000-0002-8178-9714]
dc.identifier.orcidMoretti, K. [0000-0002-6712-6551]
dc.identifier.urihttp://hdl.handle.net/2440/90248
dc.language.isoen
dc.publisherAmerican College of Physicians
dc.source.urihttps://doi.org/10.7326/l15-5063
dc.subjectHumans
dc.subjectProstatic Neoplasms
dc.subjectProstate-Specific Antigen
dc.subjectDecision Making
dc.subjectPatient Participation
dc.subjectPrimary Health Care
dc.subjectMale
dc.subjectEarly Detection of Cancer
dc.titleInformed decision making about prostate cancer screening
dc.typeJournal article
pubs.publication-statusPublished

Files